BROWSE·page 170 of 257

Browse EX-10 agreements

3,074 matching material contract exhibits.


EX-10.2

Tyra Biosciences, Inc.

TYRA BIOSCIENCES, INC.

2021 INCENTIVE AWARD PLAN

RESTRICTED STOCK Unit Grant Notice

Capitalized terms not specifically defined in this Restricted Stock Unit Grant Notice (the “Grant Notice”) have the meanings given to them in the 2021 Incentive Award Plan (as amended from time to time, the “Plan”) of Tyra Biosciences, Inc. (the “Company”).

The Company hereby grants to the participant listed below (“Participant”) the Restricted Stock Units described in this Grant Notice (the “RSUs,” and this award, the “Award”), subject to the terms and conditions of the Plan and the Restricted Stock Unit Agreement attached hereto as Exhibit A(the “Agreement”), both of which are incorporated into this Grant Notice by reference.

…

EX-10.2·10-Q·CIK 1863127·ACC 0001193125-26-332995·Filed Aug 04, 2026, 16:42 ET

EX-10.1

Tyra Biosciences, Inc.

Tyra Biosciences, Inc.

Non-Employee Director Compensation Program

(Amended and Restated Effective May 28, 2026)

Non-employee members of the board of directors (the “Board”) of Tyra Biosciences, Inc. (the “Company”) shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this “Program”). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a “Non-Employee Director”) who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company and subject to any limits on non-employee director compensation set forth in the Equity Plan (as defined below). This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the B

…

EX-10.1·10-Q·CIK 1863127·ACC 0001193125-26-332995·Filed Aug 04, 2026, 16:42 ET

EX-10.3

Tyra Biosciences, Inc.

TYRA BIOSCIENCES, INC.

COMMON STOCK
AMENDMENT NO. 1 TO SALES AGREEMENT

August 4, 2026

TD Securities (USA) LLC

1 Vanderbilt Avenue

New York, New York 10017

Ladies and Gentlemen:

Tyra Biosciences, Inc., a Delaware corporation (the “Company”), and TD Securities (USA) LLC (“TD Cowen”), are parties to that certain Sales Agreement dated May 8, 2025 (the “Original Agreement”). All capitalized terms not defined herein shall have the meanings ascribed to them in the Original Agreement. The Company and TD Cowen desire to amend the Original Agreement as set forth in this Amendment No. 1 thereto (this “Amendment”) as follows:

1.

Issuance and Sale of Shares by TD Cowen. The first paragraph of Section 1is hereby amended and restated in its entirety to read as follows:

2.

…

EX-10.3·10-Q·CIK 1863127·ACC 0001193125-26-332995·Filed Aug 04, 2026, 16:42 ET

EX-10.2

HAVERTY FURNITURE COMPANIES INC

HAVERTY FURNITURE COMPANIES, INC.
2026 LONG-TERM INCENTIVE PLAN

SECTION 1: PURPOSE

…

EX-10.2·10-Q·CIK 216085·ACC 0001628280-26-052652·Filed Aug 04, 2026, 16:38 ET

EX-10.1

HAVERTY FURNITURE COMPANIES INC

SIXTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

THIS SIXTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT(this “Amendment”), is made and entered into as of June 29, 2026 (the “Effective Date”), by and among HAVERTY FURNITURE COMPANIES, INC., a Maryland corporation (“HFC”), HAVERTYS CREDIT SERVICES, INC.,a Tennessee corporation (“HCS” and, together with HFC, each, a “Borrower” and, collectively, the “Borrowers”), the financial institutions party hereto as lenders (the “Lenders”), and TRUIST BANK, in its capacities as administrative agent for the Lenders (together with its successors in such capacity, “Administrative Agent”) and as issuing bank (together with its successors in such capacity, “Issuing Bank”).

WITNESSETH:

…

EX-10.1·10-Q·CIK 216085·ACC 0001628280-26-052652·Filed Aug 04, 2026, 16:38 ET

EX-10.1

GRAPHIC PACKAGING HOLDING CO

EIGHTH AMENDMENT TO THE

2018 US GRAPHIC PACKAGING INTERNATIONAL PENSION PLAN

(As Amended and Restated Effective January 1, 2019)

THIS AMENDMENT, to the 2018 US Graphic Packaging International Pension Plan, as amended and restated effective January 1, 2019 (the "Plan"), is made by the Retirement Committee of Graphic Packaging International, LLC ("Retirement Committee").

WITNESSETH:

WHEREAS, Graphic Packaging International, LLC (the "Company") maintains for the Plan for the benefit of its employees; and

WHEREAS, Section 4.1 of the Plan authorizes the Board of Directors of Graphic Packaging Holding Company (the "Board") to amend the Plan at any time; and

WHEREAS, the Board has delegated to the Retirement Committee of Graphic Packaging International, LLC (the "Retirement Committee") the responsibility to make certain amendments to the Plan; and

WHEREAS, the Retirement Committee desires to amend the Plan to freeze participation in the Plan for certain Plan participants, effective July 1, 2026;

…

EX-10.1·10-Q·CIK 1408075·ACC 0001408075-26-000029·Filed Aug 04, 2026, 16:38 ET

EX-10.1

PUBLIC SERVICE ENTERPRISE GROUP INC

DEFERRED COMPENSATION PLAN FOR CERTAIN EMPLOYEES

OF PUBLIC SERVICE ENTERPRISE GROUP INCORPORATED

AND ITS AFFILIATES

AMENDED AND RESTATED EFFECTIVE JULY 20, 2026


DEFERRED COMPENSATION PLAN FOR CERTAIN EMPLOYEES OF

PUBLIC SERVICE ENTERPRISE GROUP INCORPORATEDAND ITS AFFILIATES

AMENDED EFFECTIVE JULY 20, 2026

1.

PURPOSE. The original purpose of the Deferred Compensation Plan for Certain Employees of Public Service Enterprise Group Incorporated and Its Affiliates (“Plan”) is to provide a method to certain select and key employees of the Company and its Affiliates to defer compensation as provided herein. This Plan was formerly known as the Deferred Compensation Plan for Certain Employees of Public Service Electric and Gas Company. Effective November 18, 2024, the Plan provides for Core Contributions that cannot be made to the Public Service Enterprise Group Incorporated Thrift and Tax-Deferred Savings Plan (“Thrift Plan”) for certain select and key employees of the Company and its Affiliates.

2.

…

EX-10.1·10-Q·CIK 788784·ACC 0001193125-26-332943·Filed Aug 04, 2026, 16:31 ET

EX-10.3

PUBLIC SERVICE ENTERPRISE GROUP INC

PUBLIC SERVICE ENTERPRISE GROUP INCORPORATED

MANAGEMENT INCENTIVE COMPENSATION PLAN

Amended and effective July 20, 2026


TABLE OF CONTENTS

Page No.

I. PURPOSE 3
II. DEFINITIONS 4
III. ADMINISTRATION 8
IV. ELIGIBILITY 8
V. TARGET INCENTIVE AWARDS 9
VI. PERFORMANCE GOALS 10
VII. DETERMINATION OF FINAL INCENTIVE AWARDS 11
VIII. DISTRIBUTION 15
IX. TERMINATION OF EMPLOYMENT 15
X. LIMITATIONS 16
XI. LIMITATION OF ACTIONS 17
XII. CLAIMS PROCEDURE 17

…

EX-10.3·10-Q·CIK 788784·ACC 0001193125-26-332943·Filed Aug 04, 2026, 16:31 ET

EX-10.2

PUBLIC SERVICE ENTERPRISE GROUP INC

THE PUBLIC SERVICE ENTERPRISE GROUP INCORPORATED

EQUITY DEFERRAL PLAN

As amended and restated effective July 20, 2026


THE PUBLIC SERVICE ENTERPRISE GROUP INCORPORATED

EQUITY DEFERRAL PLAN

As amended and restated effective July 20, 2026

Public Service Enterprise Group Incorporated (“Company”) established the Public Service Enterprise Group Incorporated Equity Deferral Plan (“Deferral Plan”) effective as of November 1, 2011. The Company maintains the Equity Deferral Plan for a select group of management and highly compensated employees as a means of deferring the receipt of certain equity granted under the Public Service Enterprise Group Incorporated 2004 Long-term Incentive Plan and the Public Service Enterprise Group Incorporated 2021 Long-term Incentive Plan (collectively “LTIP”).

The Deferral Plan was amended effective November 20, 2023 to (i) remove the deferral election of “earlier of,” (ii) remove historical references and update examples, and (iii) clarify distribution upon termination.

…

EX-10.2·10-Q·CIK 788784·ACC 0001193125-26-332943·Filed Aug 04, 2026, 16:31 ET

EX-10.2

Alight, Inc. / Delaware

May 27, 2026

Private and Confidential

Stephen Lasher

Delivered via email:

Dear Steve,

We are pleased to extend you an offer of employment with Alight Solutions LLC (the “Company"). We believe you will make a significant contribution to our Company, and we look forward to you joining us.

Start Date

Your start date is anticipated to be around June 15, 2026, provided, however, that if the background processing procedures, contingent upon which this offer is being made, causes the start date to be extended for any reason, the date upon which you actually start work with the Company shall be deemed the “Start Date” for all purposes under this letter.

About the Role

Your position will be a full-time Chief Financial Officer, reporting to me. This role is a member of our Executive Leadership Team (ELT). It is also classified as a “Section 16 Officer” under the Securities Exchange Act of 1934, as amended. You will be primarily based out of our headquarters located in Chicago, Illinois.

Compensation

Base Salary

…

EX-10.2·10-Q·CIK 1809104·ACC 0001628280-26-052636·Filed Aug 04, 2026, 16:30 ET

EX-10.3

Alight, Inc. / Delaware

May 27, 2026

Stephen Lasher

Re: Severance Letter Agreement

Dear Steve,

Alight Solutions LLC (the “Company”) has determined that appropriate steps should be taken to reinforce and encourage the continued attention and dedication of the Company’s key employees, including you, to the Company, and recognizes the continuing importance of your work to the success of the Company. Accordingly, to encourage your continued dedication to the Company, the Company has determined to provide you with severance protections pursuant to the terms of this letter agreement.

1.    Effectiveness. This letter agreement will become effective upon the later of its execution by both parties or June 15, 2026.

…

EX-10.3·10-Q·CIK 1809104·ACC 0001628280-26-052636·Filed Aug 04, 2026, 16:30 ET

EX-10.1

Pacira BioSciences, Inc.

EXECUTIVE EMPLOYMENT AGREEMENT

This Executive Employment Agreement (the “Agreement”), is entered into as of January 21, 2025, by and between Pacira Pharmaceuticals, Inc., a California corporation, any of its past, present, or future parents, subsidiaries, predecessors, affiliates, successors, officers, directors, assigns, investors, agents, owners, managing agents and insurers (the “Company”), and Brendan Teehan (the “Executive”) (collectively, the “Parties”).

RECITALS

WHEREAS, the Company is a wholly-owned subsidiary of Pacira BioSciences, Inc., a Delaware corporation (“Parent”).

WHEREAS, the Company wishes to employ the Executive, and the Executive desires to be employed by the Company, for such purpose and upon the terms and conditions hereinafter provided, effective as of January 21, 2025 (the “Effective Date”); and

WHEREAS, the Parties wish to establish the terms of the Executive’s future employment with the Company and set out fully their respective rights, obligations and duties.

AGREEMENT

…

EX-10.1·10-Q·CIK 1396814·ACC 0001628280-26-052635·Filed Aug 04, 2026, 16:30 ET